RxDoctor Payments Data

Claudia Orellana, MD

Psychiatry · Bossier City, LANPI 1417167842

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.1% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $458 and has fallen 58.2% since, to $191 in 2025.

$1,580in general payments, 2019–2025

Across 66 payments — averaging $23.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$323
  • Lundbeck LLC$271
  • Neurocrine Biosciences, Inc.$207
  • Alkermes, Inc.$174
  • Johnson & Johnson$160
  • Otsuka America Pharmaceutical, Inc.$135
  • plus $308 from 5 others

What the payments were for

  • Food & beverage$1,47093%
  • Education$1097%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,580 in reported general payments places this provider in the 70th percentile of 474 psychiatry providers in Louisiana.

See all psychiatry providers in Louisiana →

Medicare billing

Part B allowed, 2024
$5,066
Medicare patients
35
Services billed
58

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ziprasidone Hcl28$2,018
Bupropion XlBupropion Hcl25$394
Fluphenazine Hcl15$309
Duloxetine Hcl16$273
Quetiapine Fumarate28$263
Aripiprazole14$169
Olanzapine14$165
Benztropine Mesylate21$163
Risperidone15$116
Trazodone Hcl17$116
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$82
Escitalopram Oxalate15$55
Alprazolam20$53
Zolpidem Tartrate12$47
Sertraline Hcl13$35

Paid to pharmacies, not to this prescriber.

Other psychiatry in Bossier City

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →